Allergan Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2020, Allergan Plc's inventory turnover ratio sequentially decreased to 2.37 in the first quarter 2020, unsurprisingly, as the Allergan Plc markets continue to deteriorate, and AGN's faces growing challenges to bring down its inventories. Allergan Plc's average inventory processing period in the Mar 31 2020 quarter, has increased to 154 days, from 153 days, in the Dec 31 2019 quarter.

Within Healthcare sector 230 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the First Quarter 2020 compared to previous quarter at no. 1603.

AGN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Allergan Plc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AGN Inventory Turnover Ratio	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter
Y / Y Inventory Growth	27.22 %	33.79 %	21.07 %	8.89 %	-0.55 %
Y / Y Cost of Sales Growth	25.17 %	19.32 %	7.07 %	35.39 %	-4.78 %
Inventory Turnover Ratio (TTM)	2.37	2.39	2.45	2.53	2.4
AGN's Total Ranking	# 1603	# 1603	# 1603	# 1606	# 1603
Average inventory processing period	154	152	149	144	152
Seq. Inventory Growth	5.9 %	4.62 %	7.82 %	6.5 %	11.37 %
Seq. Cost of Sales Growth	-11.49 %	10.17 %	-2.04 %	31.04 %	-15.63 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 66
Healthcare Sector	# 231
Overall Market	# 1603

Inventory Turnover Ratio Statistics
High	Average	Low
4.35	2.79	1.47
(Sep. 30, 2005)		(Jun 30 2015)

AGN Company Profile >> Back to AGN Efficiency Comparisons >> Compare AGN Inventory Turnover Ratio to its Competitors

Financial Statements
Allergan Plc's Inventories	$ 1,200 Millions	Visit AGN's Balance sheet
Allergan Plc's Cost of Revenues TTM	$ 2,618 Millions	Visit AGN's Income Statement
What are AGN's Sales?		Visit AGN's Sales by Segment

Other Inventory Turnover Ratios
Allergan Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AGN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AGN's Competitors
Inventory Turnover Ratio for AGN's Suppliers
Inventory Turnover Ratio for AGN's Customers

You may also want to know
AGN's Sales Growth Rates	AGN's Pe Price to earnings ratio	AGN's Receivables Turnover Ratio	AGN's Stock Quote
AGN's Net Income Growth Rates	AGN's Ps Price to Sales ratio	AGN's Sales per Employee	AGN's Asset Turnover Ratio
AGN's Net Margin	AGN's Pb Price to Book ratio	AGN's Financial Strength Ratios	AGN's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2020	Inventories at quarter ending Mar 31 2020
Htg Molecular Diagnostics Inc	5.99	$ 7.881 Millions	$ 1 Millions
Lantheus Holdings Inc	5.94	$ 182.802 Millions	$ 31 Millions
Inogen Inc	5.90	$ 194.412 Millions	$ 33 Millions
Lifemd Inc	5.89	$ 4.352 Millions	$ 1 Millions
Avantor Inc	5.80	$ 4,118.000 Millions	$ 710 Millions
Aquestive Therapeutics Inc	5.58	$ 20.514 Millions	$ 4 Millions
Neuronetics Inc	5.53	$ 15.393 Millions	$ 3 Millions
Gw Pharmaceuticals Plc	5.52	$ 32.837 Millions	$ 6 Millions
Invacare Holdings Corporation	5.44	$ 659.385 Millions	$ 121 Millions
Harrow Inc	5.32	$ 16.477 Millions	$ 3 Millions
West Pharmaceutical Services Inc	5.32	$ 1,262.000 Millions	$ 237 Millions
Camp4 Therapeutics Corporation	5.31	$ 222.804 Millions	$ 42 Millions
Idexx Laboratories Inc	5.28	$ 1,067.875 Millions	$ 202 Millions
Hill rom Holdings Inc	5.28	$ 1,466.200 Millions	$ 278 Millions
Patterson Companies Inc	5.24	$ 4,292.601 Millions	$ 819 Millions
Mallinckrodt Plc	5.12	$ 1,667.600 Millions	$ 326 Millions
Adm Tronics Unlimited Inc	5.11	$ 1.912 Millions	$ 0 Millions
Gilead Sciences Inc	5.10	$ 4,687.000 Millions	$ 919 Millions
Eagle Pharmaceuticals inc	5.09	$ 43.102 Millions	$ 8 Millions
Henry Schein Inc	5.09	$ 6,969.171 Millions	$ 1,370 Millions
National Vision Holdings Inc	5.00	$ 594.550 Millions	$ 119 Millions
Myriad Genetics Inc	4.84	$ 147.400 Millions	$ 30 Millions
T2 Biosystems Inc	4.84	$ 17.046 Millions	$ 4 Millions
Integrated Biopharma Inc	4.83	$ 45.961 Millions	$ 10 Millions
Endo International Plc	4.72	$ 1,566.228 Millions	$ 332 Millions
Amarin Corp Plcuk	4.69	$ 113.686 Millions	$ 24 Millions
Quorum Health Corporation	4.69	$ 185.613 Millions	$ 40 Millions
Veracyte Inc	4.66	$ 28.652 Millions	$ 6 Millions
Dexcom Inc	4.65	$ 581.400 Millions	$ 125 Millions
Zynex inc	4.51	$ 10.431 Millions	$ 2 Millions

Date modified: 2026-09-08T15:09:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.